213 related articles for article (PubMed ID: 29137407)
1. LncRNA SNHG12 contributes to multidrug resistance through activating the MAPK/Slug pathway by sponging miR-181a in non-small cell lung cancer.
Wang P; Chen D; Ma H; Li Y
Oncotarget; 2017 Oct; 8(48):84086-84101. PubMed ID: 29137407
[TBL] [Abstract][Full Text] [Related]
2. LncRNA SNHG12 Decreases Non-Small Cell Lung Cancer Cell Sensitivity to Cisplatin by Repressing miR-525-5p and Promoting XIAP.
Tan D; Wang S; Zhang P; Peng C; Wu T
Ann Clin Lab Sci; 2023 Jan; 53(1):64-75. PubMed ID: 36889771
[TBL] [Abstract][Full Text] [Related]
3. LncRNA SNHG12 in extracellular vesicles derived from carcinoma-associated fibroblasts promotes cisplatin resistance in non-small cell lung cancer cells.
Tan D; Li G; Zhang P; Peng C; He B
Bioengineered; 2022 Jan; 13(1):1838-1857. PubMed ID: 35014944
[TBL] [Abstract][Full Text] [Related]
4. Knockdown of SNHG12 suppresses tumor metastasis and epithelial-mesenchymal transition via the Slug/ZEB2 signaling pathway by targeting miR-218 in NSCLC.
Wang Y; Liang S; Yu Y; Shi Y; Zheng H
Oncol Lett; 2019 Feb; 17(2):2356-2364. PubMed ID: 30719111
[TBL] [Abstract][Full Text] [Related]
5. LncRNA SNHG12 regulates the miR-101-3p/CUL4B axis to mediate the proliferation, migration and invasion of non-small cell lung cancer.
Xie FW; Liu JC
Kaohsiung J Med Sci; 2021 Aug; 37(8):664-674. PubMed ID: 34002487
[TBL] [Abstract][Full Text] [Related]
6. Knockdown of Long Noncoding RNA Small Nucleolar RNA Host Gene 12 Inhibits Cell Growth and Induces Apoptosis by Upregulating miR-138 in Nonsmall Cell Lung Cancer.
Wang X; Qi G; Zhang J; Wu J; Zhou N; Li L; Ma J
DNA Cell Biol; 2017 Nov; 36(11):892-900. PubMed ID: 28872894
[TBL] [Abstract][Full Text] [Related]
7. LncRNA TATDN1 contributes to the cisplatin resistance of non-small cell lung cancer through TATDN1/miR-451/TRIM66 axis.
Wang L; Shang X; Feng Q
Cancer Biol Ther; 2019; 20(3):261-271. PubMed ID: 30481109
[TBL] [Abstract][Full Text] [Related]
8. DNA-methylation-mediated activating of lncRNA SNHG12 promotes temozolomide resistance in glioblastoma.
Lu C; Wei Y; Wang X; Zhang Z; Yin J; Li W; Chen L; Lyu X; Shi Z; Yan W; You Y
Mol Cancer; 2020 Feb; 19(1):28. PubMed ID: 32039732
[TBL] [Abstract][Full Text] [Related]
9. Molecular mechanism of lncRNA SNHG12 in immune escape of non-small cell lung cancer through the HuR/PD-L1/USP8 axis.
Huang Y; Xia L; Tan X; Zhang J; Zeng W; Tan B; Yu X; Fang W; Yang Z
Cell Mol Biol Lett; 2022 Jun; 27(1):43. PubMed ID: 35658874
[TBL] [Abstract][Full Text] [Related]
10. LncRNA NNT-AS1 is a major mediator of cisplatin chemoresistance in non-small cell lung cancer through MAPK/Slug pathway.
Cai Y; Dong ZY; Wang JY
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4879-4887. PubMed ID: 30070323
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of Long Noncoding RNA (lncRNA) X-Inactive Specific Transcript (XIST) is Associated with Cisplatin Resistance in Non-Small Cell Lung Cancer (NSCLC) by Downregulating MicroRNA-144-3p.
Tian LJ; Wu YP; Wang D; Zhou ZH; Xue SB; Zhang DY; Wei YG; Liu W
Med Sci Monit; 2019 Oct; 25():8095-8104. PubMed ID: 31659146
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of Long Non-Coding RNA Small Nucleolar RNA Host Gene 12 Contributes to Cell Growth and Invasion in Cervical Cancer by Acting as a Sponge for MiR-424-5p.
Dong J; Wang Q; Li L; Xiao-Jin Z
Cell Physiol Biochem; 2018; 45(5):2086-2094. PubMed ID: 29533945
[TBL] [Abstract][Full Text] [Related]
13. LncRNA SNHG1 contributes to the cisplatin resistance and progression of NSCLC via miR-330-5p/DCLK1 axis.
Ge P; Cao L; Zheng M; Yao Y; Wang W; Chen X
Exp Mol Pathol; 2021 Jun; 120():104633. PubMed ID: 33753110
[TBL] [Abstract][Full Text] [Related]
14. lncRNA small nucleolar RNA host gene 12 promotes renal cell carcinoma progression by modulating the miR‑200c‑5p/collagen type XI α1 chain pathway.
Xu C; Liang H; Zhou J; Wang Y; Liu S; Wang X; Su L; Kang X
Mol Med Rep; 2020 Nov; 22(5):3677-3686. PubMed ID: 32901847
[TBL] [Abstract][Full Text] [Related]
15. ELF1 activated long non-coding RNA CASC2 inhibits cisplatin resistance of non-small cell lung cancer via the miR-18a/IRF-2 signaling pathway.
Xiao XH; He SY
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3130-3142. PubMed ID: 32271431
[TBL] [Abstract][Full Text] [Related]
16. LncRNA SNHG12 regulates the radiosensitivity of cervical cancer through the miR-148a/CDK1 pathway.
Wang C; Shao S; Deng L; Wang S; Zhang Y
Cancer Cell Int; 2020 Dec; 20(1):554. PubMed ID: 33292254
[TBL] [Abstract][Full Text] [Related]
17. MiR-181a contributes gefitinib resistance in non-small cell lung cancer cells by targeting GAS7.
Ping W; Gao Y; Fan X; Li W; Deng Y; Fu X
Biochem Biophys Res Commun; 2018 Jan; 495(4):2482-2489. PubMed ID: 29269300
[TBL] [Abstract][Full Text] [Related]
18. Upregulation of SNHG12 accelerates cell proliferation, migration, invasion and restrain cell apoptosis in breast cancer by enhancing regulating SALL4 expression via sponging miR-15a-5p.
Yuan JH; Li WX; Hu C; Zhang B
Neoplasma; 2020 Jul; 67(4):861-870. PubMed ID: 32386479
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA SNHG12 promotes the progression of cervical cancer via modulating miR-125b/STAT3 axis.
Jin XJ; Chen XJ; Zhang ZF; Hu WS; Ou RY; Li S; Xue JS; Chen LL; Hu Y; Zhu H
J Cell Physiol; 2019 May; 234(5):6624-6632. PubMed ID: 30246459
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic role of long non-coding RNA SNHG12 in gastric cancer cells by targeting miR-16.
Zhao G; Wang S; Liang X; Wang C; Peng B
Exp Ther Med; 2019 Jul; 18(1):199-208. PubMed ID: 31258654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
